These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 8981312)

  • 1. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress.
    Deibel MA; Ehmann WD; Markesbery WR
    J Neurol Sci; 1996 Nov; 143(1-2):137-42. PubMed ID: 8981312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease.
    Aksenov MY; Tucker HM; Nair P; Aksenova MV; Butterfield DA; Estus S; Markesbery WR
    J Mol Neurosci; 1998 Oct; 11(2):151-64. PubMed ID: 10096042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain.
    Smith JL; Xiong S; Markesbery WR; Lovell MA
    Neuroscience; 2006 Jul; 140(3):879-88. PubMed ID: 16580781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain.
    Cornett CR; Markesbery WR; Ehmann WD
    Neurotoxicology; 1998 Jun; 19(3):339-45. PubMed ID: 9621340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scavenger receptor class B type I expression and elemental analysis in cerebellum and parietal cortex regions of the Alzheimer's disease brain.
    Srivastava RA; Jain JC
    J Neurol Sci; 2002 Apr; 196(1-2):45-52. PubMed ID: 11959156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease.
    Lovell MA; Smith JL; Xiong S; Markesbery WR
    Neurotox Res; 2005; 7(4):265-71. PubMed ID: 16179263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unaltered brain levels of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in Alzheimer's disease.
    Götz ME; Wacker M; Luckhaus C; Wanek P; Tatschner T; Jellinger K; Leblhuber F; Ransmayr G; Riederer P; Eder E
    Neurosci Lett; 2002 May; 324(1):49-52. PubMed ID: 11983292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.
    Lovell MA; Ehmann WD; Butler SM; Markesbery WR
    Neurology; 1995 Aug; 45(8):1594-601. PubMed ID: 7644059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease.
    Lovell MA; Xie C; Markesbery WR
    Neurology; 1998 Dec; 51(6):1562-6. PubMed ID: 9855502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallostasis in Alzheimer's disease.
    Ayton S; Lei P; Bush AI
    Free Radic Biol Med; 2013 Sep; 62():76-89. PubMed ID: 23142767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper, iron and zinc in Alzheimer's disease senile plaques.
    Lovell MA; Robertson JD; Teesdale WJ; Campbell JL; Markesbery WR
    J Neurol Sci; 1998 Jun; 158(1):47-52. PubMed ID: 9667777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elemental imbalances in the olfactory pathway in Alzheimer's disease.
    Samudralwar DL; Diprete CC; Ni BF; Ehmann WD; Markesbery WR
    J Neurol Sci; 1995 Jun; 130(2):139-45. PubMed ID: 8586977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterising the brain metalloproteome in Down syndrome patients with concomitant Alzheimer's pathology.
    Malakooti N; Roberts B; Pritchard MA; Volitakis I; Kim RC; Lott IT; McLean CA; Finkelstein DI; Adlard PA
    Metallomics; 2020 Jan; 12(1):114-132. PubMed ID: 31764918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
    Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Merchant M; Markesbery WR; Butterfield DA
    Neurobiol Aging; 2006 Nov; 27(11):1564-76. PubMed ID: 16271804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion.
    Schrag M; Mueller C; Oyoyo U; Smith MA; Kirsch WM
    Prog Neurobiol; 2011 Aug; 94(3):296-306. PubMed ID: 21600264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum zinc levels and Alzheimer's disease.
    Rulon LL; Robertson JD; Lovell MA; Deibel MA; Ehmann WD; Markesber WR
    Biol Trace Elem Res; 2000; 75(1-3):79-85. PubMed ID: 11051598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
    Butterfield DA; Reed TT; Perluigi M; De Marco C; Coccia R; Keller JN; Markesbery WR; Sultana R
    Brain Res; 2007 May; 1148():243-8. PubMed ID: 17395167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodies.
    Graham SF; Nasaruddin MB; Carey M; Holscher C; McGuinness B; Kehoe PG; Love S; Passmore P; Elliott CT; Meharg AA; Green BD
    J Alzheimers Dis; 2014; 42(4):1407-13. PubMed ID: 25024342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease.
    Völkel W; Sicilia T; Pähler A; Gsell W; Tatschner T; Jellinger K; Leblhuber F; Riederer P; Lutz WK; Götz ME
    Neurochem Int; 2006 Jun; 48(8):679-86. PubMed ID: 16483694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific temporoparietal gyral atrophy reflects the pattern of language dissolution in Alzheimer's disease.
    Harasty JA; Halliday GM; Kril JJ; Code C
    Brain; 1999 Apr; 122 ( Pt 4)():675-86. PubMed ID: 10219781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.